Δευτέρα 13 Μαρτίου 2017

NICE recommends ixekizumab for persistent severe plaque psoriasis

The National Institute for Health and Care Excellence (NICE), in its final draft guidance issued this week, has recommended ixekizumab, an antibody that inhibits interleukin-17A, as an option for...
recent?d=yIl2AUoC8zA recent?d=dnMXMwOfBR0 recent?i=M3W_-obNtOc:GIPvBabEjqI:V_sGLiP recent?d=qj6IDK7rITs recent?i=M3W_-obNtOc:GIPvBabEjqI:gIN9vFw recent?d=l6gmwiTKsz0 recent?d=7Q72WNTAKBA recent?i=M3W_-obNtOc:GIPvBabEjqI:F7zBnMy recent?i=M3W_-obNtOc:GIPvBabEjqI:-BTjWOF


from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2mC7N9Y
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Δημοφιλείς αναρτήσεις